20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function
HD                     :Unlikely to be dialysed. Dose as in normal renal function
HDF/high flux   :Dialysed. Dose as in normal renal function
CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntagonises effect of coumarins and phenindione
ADMINISTRATION
Reconstition
–
Route
IV, IM, oral
Rate of Administration
Konakion ® – very slow injection (1 mg/min)Konakion MM ® – dilute each 10 mg with 55 mL of glucose 5% and give by slow infusion over 15–30 minutes
Comments
Risk of anaphylaxis if IV injected too rapidlyProtect infusion from light Konakion ® should not be diluted (non-micellar)Only Konakion can be given IM
OTHER INFORMATION
recommended for severe haemorrhage
Anticoagulation antidote: re-test prothrombin time 8–12 hours after Konakion, 3 hours after Konakion MM – repeat dose if inadequatePatients with obstructive jaundice requiring oral vitamin K should be prescribed the water-soluble preparation menadiol sodium diphosphate – dosage range is similar